Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02215096 |
| Title | Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
| GSK Investigational Site | Los Angeles | California | 90033 | United States | Details | |
| GSK Investigational Site | Los Angeles | California | 90095 | United States | Details | |
| GSK Investigational Site | Washington | District of Columbia | 20007 | United States | Details | |
| GSK Investigational Site | Detroit | Michigan | 48201 | United States | Details | |
| GSK Investigational Site | New York | New York | 10016 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | London | SE1 9RT | United Kingdom | Details | ||
| GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |